Sernova (TSE:SVA) Shares Down 12.9% – Here’s What Happened

Sernova Corp. (TSE:SVA) dropped 12.9% during trading on Monday . The stock traded as low as C$0.14 and last traded at C$0.14. Approximately 105,351 shares changed hands during mid-day trading, a decline of 20% from the average daily volume of 131,265 shares. The stock had previously closed at C$0.16.

Sernova Stock Performance

The company has a current ratio of 0.32, a quick ratio of 18.11 and a debt-to-equity ratio of -4.40. The business’s 50-day moving average is C$0.14 and its two-hundred day moving average is C$0.16. The firm has a market cap of C$48.82 million, a P/E ratio of -2.90 and a beta of 0.44.

Sernova Company Profile

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. A bio-hybrid organ refers to a medical device designed to be implanted into the human body, where it integrates with existing living tissue to replicate or enhance the function of a natural organ, essentially aiming to restore normal organ function by combining living cells with non-living materials to mimic the properties of the original organ and seamlessly interact with surrounding tissues.